Logo
Login
$BMRN
$55.35 -$0.40 (0.72%) Close

Company Executives

$BMRN Management Team

Dr. C. Greg Guyer

Executive Vice President and Chief Technical Officer

Age 63
Compensation $5.701M USD
Sex Male

Dr. James Sabry

Chief Business Officer

Age 66
Compensation -
Sex Male

Mr. G. Eric Davis

Executive Vice President

Secretary

Chief Legal Officer

Age 54
Compensation $5.059M USD
Sex Male

Dr. Gregory Friberg

Executive Vice President

Chief Research & Development Officer

Age 51
Compensation $7.222M USD
Sex Male

Ms. Cristin Hubbard

Executive Vice President

Chief Commercial Officer

Age 49
Compensation $6.928M USD
Sex Female

Mr. Richard Meier

Non-Executive Independent Chairman of the Board

Age 65
Compensation $719.1K USD
Sex Male

Mr. Alexander Hardy

President

Chief Executive Officer

Director

Age 56
Compensation $14.85M USD
Sex Male

Mr. Brian Mueller

Chief Financial Officer

Executive Vice President and Principal Financial Officer

Age 51
Compensation $5.499M USD
Sex Male

Mr. Arpit Dave

Executive Vice President

Chief Digital and Information Officer

Age -
Compensation -
Sex Male

Ms. Rashmi Ramchandani

Chief Accounting Officer

Vice President

Age 47
Compensation -
Sex Female

Board of Directors

From the proxy statement filed Apr 21, 2026
Directors
11
serving now
Independent
10 of 11
stated in the proxy
Average tenure
4.5 years
from year joined
CEO also chairs the board
No
Ian T. Clark
Director Age On board Independent Committees Other public boards 2025 pay Source
Elizabeth McKee Anderson
68 2019
7 years
 Independent
Compensation Committee · Chair
GSK plc, Insmed, Inc., Revolution Medicines, Inc. $505,035
Barbara W. Bodem
58 2023
3 years
 Independent None stated Enovis Corp., Option Care Health, Inc. $487,035
Ian T. Clark
Board chair
 65 2025
1 year
 Independent None stated None stated $451,230
Athena Countouriotis
54 2023
3 years
 Independent None stated Iovance Biotherapeutics, Inc. $493,660
Willard Dere
72 2016
10 years
 Independent
Science and Technology Committee · Chair
Seres Therapeutics, Inc., Metagenomi, Inc. $509,035
Mark J. Enyedy
62 2023
3 years
 Independent
CGN Committee · Chair
Charles River Laboratories International, Inc. $501,285
Alexander Hardy
CEO
 57 2023
3 years
 Not independent None stated None stated Paid as CEO
Maykin Ho
73 2021
5 years
 Independent None stated Agios Pharmaceuticals Inc., Kyntra Bio, Inc., Neumora Therapeutics, Inc. Not stated
Robert J. Hombach
60 2017
9 years
 Independent
Audit Committee · Chair
Embecta Corporation $509,535
Timothy P. Walbert
59 2025
1 year
 Independent None stated Mirum Pharmaceuticals, Inc., Century Therapeutics, Inc., Sagimet Biosciences Inc. $492,785
Meier Leaving at the meeting
Not stated Not stated Independent None stated None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

No related-party transactions disclosed

The proxy filed Apr 21, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans